Version history
Lilly Together™
34
ASO score
Text
38/100
Reviews
0/100
Graphic
60/100
Other
0/100
App Rating
4.1
Votes
66
App Age
3y 10m
Last Update
Sep 29, 2025
Compare with Category Top Apps
|
Metrics
|
Current App
|
Category Top Average
|
Difference
|
|---|---|---|---|
|
Rating
|
0
|
4.69
|
|
|
Number of Ratings (Voted)
|
0
|
840.8K
|
|
|
App Age
|
3y 9m
|
9y 1m
|
-58%
|
|
In-app Purchases Price
|
$0
|
$48
|
|
|
Update Frequency
|
99d
|
19d
|
+409%
|
|
Title Length
|
15
|
27
|
-44%
|
|
Subtitle Length
|
29
|
28
|
+4%
|
|
Description Length
|
3 189
|
3 288
|
-3%
|
|
Number of Screenshots
|
150
|
1517
|
-90
%
|
|
Size
|
118MB
|
347MB
|
-66
%
|
Category Ranking in United States
7 days
Last 7 days
Last 30 days
Last 90 days
Last 180 days
Last year
| Top | Dec 30, 2025 | Jan 06, 2026 |
|---|---|---|
|
No results were found!
|
||
| Top | Dec 30, 2025 | Jan 06, 2026 |
|---|---|---|
|
No results were found!
|
||
| Top | Dec 30, 2025 | Jan 06, 2026 |
|---|---|---|
|
No results were found!
|
||
| Top | Dec 30, 2025 | Jan 06, 2026 |
|---|---|---|
|
No results were found!
|
||
Ranking Keywords in United States
| Keywords | App Rank |
|---|
Analyze this and other apps using Asolytics tools
Text ASO
Title
(
Characters:
15
of 30
)
Lilly Together™
Subtitle
(
Characters:
29
of 30
)
Medication & Tracking Support
Description
(
Characters:
3189
of 4000
)
Lilly Together™ is designed to help you as a Taltz® (ixekizumab), Olumiant® (baricitinib), EBGLYSS® (lebrikizumab-lbkz), or Omvoh® (mirikizumab- mrkz) user to manage your condition.
Please see Indications and Safety Summary including WARNINGS for Olumiant® (baricitinib) at https://olumiant.lilly.com/?section=isi
The Lilly Together™ app is a resource to help you manage your treatment journey. Key Lilly Together features include:
· Plan Setup: Set up your dosing plan, schedule dosing reminders, and track when to take your medication.
· Treatment Map: View your treatment map for a summary of what to expect during your first 6 months of treatment, including treatment touchpoints, recommended dosing, and symptom tracking.
· Dose/Medication Tracking: Log your injections or infusions to view if you are staying on track and taking your medication as your Healthcare Provider prescribed.
· Symptom Tracking: Track and monitor your symptoms over time. You can take photos that will not appear in your camera roll to keep all your symptom information in one location.
· Progress: The app puts you in control of tracking your progress, which may help you to have better conversations with your Healthcare provider.
· Logbook Report: Download a logbook report for a 90-day view of your symptom and dosing trends. This may help you understand the progress you're making on treatment so you can share the information with your Healthcare Provider.
· Additional Features: The app also offers savings card enrollment, helpful resources, and one-click- away customer support
The app offers savings card enrollment, features to help you track dosing and treatment progress, helpful resources, and one-click-away support with your Companion in Care™ team* who can also answer any questions you might have about injection training and provide the ongoing support you may need.
Note: This app is intended for the exclusive use of U.S. residents 18 years of age and older. Lilly Together™ is not intended to provide diagnostic and/or treatment decisions or replace the care and advice of a licensed Healthcare Provider. All medical analysis and treatment plans should be performed by a licensed Healthcare Provider.
Still have questions?
You can call for additional support at 1-844-486- 8546.
Lilly Together™ is a trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
Taltz® and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
Olumiant® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
Omvoh® and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
EBGLYSS® and its delivery device base registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
Lilly Support Services™, and Companion in Care™ are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates
* Your Companion in Care provided is not a medical professional. Your doctor is your source for medical advice.
PP-LU-US-0732
}
Read more
Other
Additional Information
😢
Deleted from App Store
| Rating: | |
| Voted: | 66 |
| App Store Link: | |
| Website: | - |
| Email: | - |
| Privacy Policy: | |
| Categories: | Health & Fitness, Medical |
| Size: | 117MB |
| App Age: | 3 years 10 months |
| Release Date: | Mar 16, 2022 |
| Last Update: | Sep 29, 2025 |
| Version: | 18.0.0 |
Version history
18.0.0
Sep 29, 2025
Performance updates
17.0.0
Apr 16, 2025
The latest version contains:
• Medication and tracking support for adults with moderately to severely active Crohn’s disease and prescribed Omvoh® (mirikizumab-mrkz):
o Access information about your medication and possible savings
o Log your injections and view plan for upcoming doses
o Log and monitor your symptoms over time in the logbook
o Access a treatment map that allows you to see key steps in your treatment journey
o Create a logbook report that you can save and share outside of the app with your Healthcare Provider